It may sound crazy, but I am grateful for the FUD created by those questioning the efficacy of leronlimab, the financial security of CytoDyn, and the quality of their management team.
If the intended purpose of the FUD was to weaken shareholder resolve, I for one will have to say the experiment was an unequivocal failure. But, where it succeeded was the unintended consequence of pointing concerned investors to the exact areas to research and conduct their own due diligence.
That DD has resulted in our validating of the science behind leronlimab through moments like when heralded scientist Dr. Bruce Patterson so eloquently explained leronlimab’s MOA in Covid during his TEDx discussion, the financial obstacles CytoDyn needed to focus on as they move from a pre-revenue to a commercially viable company which they’ve managed to maneuver thus far, and the holes they had in their management structure which most recently brought Mahboob U. Rahman, M.D., PhD. FACR, as the Chief Scientific Officer.
The FUD has also allowed us to personally view the lengths to which some have gone to damage this company and those invested in CYDY. We’ve witnessed a one-time celebrated journalist, the self-proclaimed Night King of Biotech Adam Feurstein being publicly disgraced following his attempt to manipulate a patient fighting for her life interfering in her participation of an FDA clinical trial. We’ve endured a barrage of insulting, inaccurate, and half-truth filled blogs by BuyersStrike! We’ve experienced a very public act of collusion on June 30, 2020 when Andrew Left of Citron published an article filled with outright lies (with a shelf life of ~2 hours before being removed from its site) was used as a trigger for a coordinated short attack with individuals bragging on message boards about their profits coming from innocent investors unknowingly caught in the middle of this fraudulent scheme to submit misinformation in an effort to profit from their efforts. And, most recently, uncovering the use of redacted FOIA documents addressed to Jacob Ma-Weaver of Cabal Car Capital that was distributed to CulperResearch and various other entities which used the document to “suggest” the letter represented proof of an ongoing SEC investigation into CytoDyn for the purpose of manipulating the stock for personal gain which some might call fraudulent behavior. The Weaver letter then led to uncovering similar FOIA requests from Brian Z. Barr associated with Wolfson Group and Mark Gleason of HyGro Partners which are also hedge funds with a history of short-selling concerns.
When you put things into context, you would have to possess a very good imagination to fabricate what I’ve written b/c, you can’t make this shit up!!! Everything I’ve mentioned is readily available for anyone willing to uncover for yourself if you just show a bit of intellectual curiosity. It ain’t going away either, no matter how bad some may want it to fade into oblivion... You have to ask yourself... What scares people about CytoDyn that they would go to these extremes to damage its reputation and attempt to suppress its lead drug leronlimab from reaching those in need? I’m sure you know that’s a rhetorical question and I will leave it for you to ponder...
Through all of these obstacles, trials and tribulations... CytoDyn remains, growing stronger, and more relevant everyday! We’re almost there everyone... DON’T BLINK!!!
“The harder you try to suppress the truth, the more inevitable it is that it will find a way to come out.”- Arianna Huffington
